OXGF(SZ:300082)2018-10-26 16:00Financial Performance - Operating revenue for the reporting period was ¥2,283,688,876.14, representing a 50.41% increase compared to the same period last year[8]. - Net profit attributable to shareholders of the listed company was ¥127,042,673.65, up 63.92% year-on-year[8]. - The basic earnings per share for the reporting period was ¥0.1864, an increase of 63.22% compared to the same period last year[8]. - The weighted average return on net assets was 4.28%, an increase of 1.48 percentage points year-on-year[8]. - Total operating revenue for the third quarter reached ¥2,283,688,876.14, a significant increase from ¥1,518,261,861.00 in the same period last year, representing a growth of approximately 50.3%[39]. - Net profit attributable to the parent company was ¥127,042,673.65, compared to ¥77,504,212.22 in the previous year, marking an increase of about 63.9%[40]. - The net profit for the third quarter of 2018 was CNY 27,546,805.74, an increase from CNY 16,468,429.48 in the same period last year, representing a growth of approximately 67.2%[52]. - Operating profit reached CNY 27,095,721.90, compared to CNY 15,599,953.88 in the previous year, indicating a year-over-year increase of about 73.8%[52]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,346,096,636.95, an increase of 0.71% compared to the end of the previous year[8]. - Net assets attributable to shareholders of the listed company amounted to ¥3,036,376,302.73, reflecting a growth of 6.25% year-on-year[8]. - The company's total assets decreased to ¥3,063,248,542.85 from ¥3,114,640,804.68 at the beginning of the period, reflecting a decline of approximately 1.6%[36]. - The total liabilities decreased to RMB 3.01 billion from RMB 3.16 billion[34]. - The company's total equity rose to RMB 3.33 billion from RMB 3.14 billion[34]. - The total equity of the company decreased to ¥2,496,606,700.66 from ¥2,543,556,728.95, a decline of about 1.8%[37]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥189,779,119.89, down 22.99% compared to the previous year[8]. - The cash flow from operating activities generated a net amount of CNY 189,779,119.89, down from CNY 246,419,994.27 in the previous year, showing a decrease of about 23.0%[56]. - The cash flow from financing activities resulted in a net outflow of CNY 193,317,905.39, compared to a net outflow of CNY 120,593,311.31 in the previous year, showing an increase in cash outflow of approximately 60.4%[57]. - The net cash flow from investment activities was 39,802,600.90 CNY, a decrease from 40,648,480.73 CNY in the previous period[60]. - The total cash and cash equivalents at the end of the period were 60,543,077.39 CNY, down from 91,381,411.26 CNY[60]. Shareholder Information - The top ten shareholders held a combined 53.31% of the shares, with 奥克控股集团股份公司 being the largest shareholder at 53.31%[12]. - The company did not engage in any repurchase transactions among the top ten shareholders during the reporting period[15]. Operational Highlights - Operating costs increased by CNY 1,511.40 million, a growth of 42.61%, corresponding to the rise in sales volume and costs[20]. - Financial expenses increased by CNY 48.48 million, a growth of 128.01%, due to currency depreciation and increased working capital borrowing needs[21]. - Other income increased by CNY 5.20 million, a growth of 575.55%, due to reclassification of government subsidies[21]. - The company successfully tested the production of high-purity vinyl carbonate with a new technology, marking a significant breakthrough in its R&D efforts[24]. - The company terminated an investment agreement with Huifeng Chemical, resulting in the release of related guarantees[23]. Investment and R&D - The company reported an investment income of ¥15,058,635.11, a turnaround from a loss of -¥3,142,665.23 in the previous year, indicating improved investment performance[40]. - Research and development expenses were reported at -¥106,778.64, a significant decrease compared to ¥15,096,121.86 in the previous year, indicating a reduction in R&D spending[39]. - Research and development expenses decreased to $5.68 million, down 9.7% from $6.29 million in the previous period[43].